全文获取类型
收费全文 | 2485篇 |
免费 | 143篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 79篇 |
妇产科学 | 49篇 |
基础医学 | 387篇 |
口腔科学 | 52篇 |
临床医学 | 209篇 |
内科学 | 626篇 |
皮肤病学 | 101篇 |
神经病学 | 216篇 |
特种医学 | 43篇 |
外科学 | 191篇 |
综合类 | 8篇 |
预防医学 | 222篇 |
眼科学 | 38篇 |
药学 | 195篇 |
中国医学 | 10篇 |
肿瘤学 | 190篇 |
出版年
2024年 | 5篇 |
2023年 | 33篇 |
2022年 | 58篇 |
2021年 | 133篇 |
2020年 | 50篇 |
2019年 | 94篇 |
2018年 | 103篇 |
2017年 | 71篇 |
2016年 | 70篇 |
2015年 | 75篇 |
2014年 | 92篇 |
2013年 | 139篇 |
2012年 | 190篇 |
2011年 | 213篇 |
2010年 | 104篇 |
2009年 | 85篇 |
2008年 | 156篇 |
2007年 | 150篇 |
2006年 | 147篇 |
2005年 | 140篇 |
2004年 | 133篇 |
2003年 | 119篇 |
2002年 | 110篇 |
2001年 | 12篇 |
2000年 | 4篇 |
1999年 | 11篇 |
1998年 | 23篇 |
1997年 | 11篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 5篇 |
1993年 | 5篇 |
1992年 | 7篇 |
1990年 | 3篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 6篇 |
1985年 | 5篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1969年 | 2篇 |
1927年 | 3篇 |
排序方式: 共有2648条查询结果,搜索用时 15 毫秒
91.
Abanto J Ciamponi AL Francischini E Murakami C de Rezende NP Gallottini M 《Special care in dentistry》2011,31(6):197-203
When planning the dental treatment of patients with Down syndrome (DS), dental practitioners should always consider their general health, in order to achieve a holistic and interdisciplinary approach. This article presents a literature review of the primary medical conditions in patients with DS that may affect their general health care and the appropriate clinical delivery of oral health care. 相似文献
92.
93.
94.
95.
Case series of pulsed dye laser treatment of telangiectasia in 23 patients with systemic sclerosis 下载免费PDF全文
96.
Giuseppe Grosso Antonio Mistretta Stefano Marventano Roberta Ferranti Luisa Mauro Rosario Cunsolo Lidia Proietti Mariano Malaguarnera 《Hepatitis monthly》2012,12(9)
Background
The impact of hepatitis B virus (HBV) vaccination campaigns on HBV epidemiology needs to be evaluated, in order to assess the long-term immunity offered by vaccines against HBV.Objectives
To evaluate the current status of anti-HBV vaccine coverage among healthcare workers (HCWs) in Southern Italy, and to determine the long-term persistence of antibodies to hepatitis B surface antigens (anti-HBs) in such a cohort of subjects.Patients and Methods
A longitudinal, retrospective seroepidemiological survey was conducted among 451 HCWs, who were working at or visiting, the Occupational Health Department of a city hospital, in Catania, Italy, between January 1976 and December 2010.Results
At the 30-year follow-up (mean follow-up 10.15 ± 5.96 years, range 0.74-30), 261 HCWs had detectable anti-HBs titers indicating a persistence of seroprotection of 89.4% (out of 292 anti-HBs positive results, three months after vaccination). An inadequate vaccination schedule was the strongest predictor of antibody loss during follow-up (OR = 8.37 95% CI: 5.41-12.95, P < 0.001). A Kaplan-Maier survival curve revealed that the persistence of anti-HBs 30 years after vaccination, was 92.2% for high responders, while it was only 27.3% for low responders (P = 0.001).Conclusions
A good level of seroprotection persisted in 57.9% of the subjects after 30 years. Factors related to this immunization status confirmed the importance of vaccinating HCWs early in their careers and ensuring an adequate vaccination schedule. However, with particular reference to the low rate of hepatitis B vaccine coverage among HCWs in Southern Italy, the implementation of a new educational intervention as part of an active vaccination program is needed. 相似文献97.
Catriona M. Steele Woroud Abdulrahman Alsanei Sona Ayanikalath Carly E. A. Barbon Jianshe Chen Julie A. Y. Cichero Kim Coutts Roberto O. Dantas Janice Duivestein Lidia Giosa Ben Hanson Peter Lam Caroline Lecko Chelsea Leigh Ahmed Nagy Ashwini M. Namasivayam Weslania V. Nascimento Inge Odendaal Christina H. Smith Helen Wang 《Dysphagia》2015,30(2):272-273
98.
Di Vito L Broglio F Benso A Gottero C Prodam F Papotti M Muccioli G Dieguez C Casanueva FF Deghenghi R Ghigo E Arvat E 《Clinical endocrinology》2002,56(5):643-648
OBJECTIVE: Ghrelin, a 28-amino-acid peptide purified from the stomach and showing a unique structure with an n-octanoyl ester at the serine 3 residue, is a natural ligand of the GH secretagogue (GHS) receptor (GHS-R). Ghrelin strongly stimulates GH secretion in both animals and humans, showing a synergistic effect with GH-releasing hormone (GHRH) but no interaction with synthetic GHS. However, the activity of ghrelin as well as that of non-natural GHS is not fully specific for GH; ghrelin also induces a stimulatory effect on lactotroph and corticotroph secretion, at least in humans. DESIGN: To further clarify the mechanisms underlying the GH-releasing activity of this natural GHS, we studied the effects of somatostatin (SS, 2.0 microg/kg/h from -30 to +90 min) on the endocrine responses to ghrelin (1.0 microg/kg i.v. at 0 min) in seven normal young male volunteers [age (mean +/- SEM) 28.6 +/- 2.9 years; body mass index (BMI) 22.1 +/- 0.8 kg/m2]. In the same subjects, the effect of SS on the GH response to GHRH (1.0 microm/kg i.v. at 0 min) was also studied. MEASUREMENTS: Blood samples were taken every 15 min from -30 up to +120 min. GH levels were assayed at each time point in all sessions; PRL, ACTH and cortisol levels were assayed after ghrelin administration alone and during SS infusion. RESULTS: The GH response to ghrelin (hAUC0'-->120' 2695.0 +/- 492.6 microg min/l) was higher (P < 0.01) than that after GHRH (757.1 +/- 44.1 microg min/l). SS infusion almost abolished the GH response to GHRH (177.0 +/- 37.7 microg min/l, P < 0.01); the GH response to ghrelin was inhibited by SS (993.8 +/- 248.5 microg min/l, P < 0.01) but GH levels remained higher (P < 0.05) than with GHRH. Ghrelin induced significant increases in PRL, ACTH and cortisol levels and these responses were not modified by SS. CONCLUSIONS: Ghrelin, a natural GHS-R ligand, exerts a strong stimulatory effect on GH secretion in humans and this effect is only blunted by an exogenous somatostatin dose which almost abolishes the GH response to GHRH. The stimulatory effect of ghrelin on lactotroph and corticotroph secretion is refractory to exogenous somatostatin, indicating that these effects occur through pathways independent of somatostatinergic influence. 相似文献
99.
Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication 总被引:1,自引:0,他引:1
Dziegiel P Murawska-Ciałowicz E Jethon Z Januszewska L Podhorska-Okołów M Surowiak P Zawadzki M Rabczyński J Zabel M 《Journal of pineal research》2003,35(3):183-187
The study aimed at determining the effect of melatonin on the activity of protective antioxidative enzymes in the heart and of lipid peroxidation products in the course of intoxication with doxorubicin (DOX). The rats were categorized into four groups, receiving: 0.9% NaCl i.p. (NaCl control); melatonin [20 mg/kg body weight (b.w.)] s.c. (control Mel); DOX (2.5 mg/kg b.w.) i.p.; melatonin plus DOX in doses as above. All the substances were administered once in a week for four consecutive weeks. Homogenates of heart tissue were examined for activities of glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT), levels of reduced glutathione (GSH) and of lipid peroxidation indices (MDA + 4-HDA). Administration of melatonin alone did not induce alterations in levels of MDA + 4-HDA, GSH, or in activity of GPx, SOD or CAT, as compared to the group receiving 0.9% NaCl. GSH levels decreased following DOX but remained at normal levels following DOX and melatonin. The level of MDA + 4-HDA increased following DOX, as compared with the control, a change prevented by the combination of DOX + melatonin. Activities of GPx, SOD and CAT were higher in groups receiving DOX and/or DOX plus melatonin than in control groups. Activity of CAT and the level of GSH in the group receiving DOX plus melatonin were significantly higher than in the group intoxicated with DOX alone. The obtained results demonstrate that, when given in parallel with DOX, melatonin protects cardiomyocytes from damaging effects of the cytostatic drug (reflected by the levels of MDA + 4-HDA). The protective effect resulted, in part from the augmented levels of GSH and from stimulation of CAT activity by melatonin in cardiomyocytes subjected to the action of DOX. 相似文献
100.
Suvi Liimatainen Maria Peltola Lidia Sabater Mahdi Fallah Elham Kharazmi Anna‐Maija Haapala Prasun Dastidar Mikael Knip Albert Saiz Jukka Peltola 《Epilepsia》2010,51(5):760-767
Purpose: Glutamic acid decarboxylase antibodies (GADAs) have been detected in patients with epilepsy, but the clinical determinants of epilepsy associated with GADA have not been defined. Methods: We analyzed GADA with a radioimmunoassay in sera of 253 well‐characterized patients with epilepsy and 200 control subjects. The positive samples were confirmed by immunohistochemistry and western blotting (WB). Sera were screened for other autoantibodies. Results: GADA were detected in 15 patients (5.9%) and in three control subjects (1.5%) (p = 0.026). Seven patients (2.8%) had high GADA titers [≥1,000 relative units (RUs)/ml], six of whom had temporal lobe epilepsy (TLE). All three GADA‐positive control subjects had low titers. Two of the five patients with high GADA titers and available cerebrospinal fluid (CSF) samples had intrathecal synthesis (IS) of GADA; one patient had CSF oligoclonal bands. The prevalence of increased levels of GADA tended to be higher in patients with TLE than in patients with extra‐TLE [odds ratio (OR) 1.32, 95% confidence interval (CI) 0.39–4.42; p = 0.657]. The patients with high GADA titers had significantly higher number of other autoantibodies compared to the patients with low GADA titers (p = 0.001) and the patients with normal GADA (p < 0.001). Discussion: High GADA titers were present in a subgroup of patients; close to 90% had TLE. The immunologic profile of these patients suggests that the most probable origin of their epilepsy is autoimmune. A positive IS of GADA may be a marker of an ongoing immune response that could identify those patients in whom a trial with immunosuppressive therapy might be warranted. 相似文献